IFN-γ upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma

International Journal of Cancer

Volumn 100, Issue 4, 2002, Pages 445-451

  Vissers, Joost L M ^a   De Vries, I Jolanda M ^a   Engelen, Linda P H ^a   Scharenborg, Nicole M ^a   Molkenboer, Janneke ^a   Figdor, Carl G ^a   Oosterwijk, Egbert ^a   Adema, Gosse J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Cholangiocarcinoma; Fas; IFN ; Tumorigenesis

Indexed keywords

CALMODULIN INHIBITOR; CASPASE; CASPASE 3; CASPASE 4; CASPASE 7; CASPASE 8; CYTOCHROME C; FAS ANTIBODY; FAS ANTIGEN; GAMMA INTERFERON; PROTEIN BAK; PROTEIN BAX; TAMOXIFEN; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAK1 PROTEIN, HUMAN; BAX PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR VOLUME; BILE DUCT TUMOR; CARCINOGEN TESTING; CELL CULTURE; DRUG EFFECT; GENETIC VARIABILITY; INTRAHEPATIC BILE DUCT; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION;

ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL TRANSPORT; CARCINOGENICITY TESTS; CASPASES; CHOLANGIOCARCINOMA; CYTOCHROME C GROUP; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VARIATION (GENETICS);

EID: 0036667263     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10516     Document Type: Article

References (54)

1. Apoptosis in the pathogenesis and treatment of disease
2. Histopathological evaluation of apoptosis in cancer
3. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
4. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
5. Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas
6. Thymineless death in colon carcinoma cells is mediated via fas signaling
7. Fas expression and function in normal and malignant breast cell lines
8. Fas/APO-1 gene transfer for human malignant glioma
9. Human lung carcinomas express Fas ligand
10. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
11. Interferon-activated signal transduction to the nucleus
12. The molecular cell biology of interferongamma and its receptor
13. Cellular responses to interferon-gamma
14. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice
15. The IFN-gamma receptor: A paradigm for cytokine receptor signaling
16. Interferongamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
17. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression
18. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma
19. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin
20. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells
21. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis
22. Interferon-gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells
23. Intrahepatic bile duct carcinoma (cholangiocarcinoma) [in Japanese]
24. Surgical treatment of cholangiocarcinoma
25. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma
26. Cholangiocarcinomas express Fas ligand and disable the Fas receptor
27. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance
28. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin
29. Fas expression prevents cholangiocarcinoma tumor growth
30. Evidence for gene silencing by endogenous DNA methylation
31. Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells
32. DNA methylation: Regulation of gene expression and role in the immune system
33. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
34. Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation
35. Potentiation of Fasmediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide
36. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
37. The Bcl-2 protein family: Arbiters of cell survival
38. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
39. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
40. Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma
41. Cancer. p53, guardian of the genome
42. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
43. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
44. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
45. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis
46. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma
47. I-FLICE a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
48. Inhibition of death receptor signals by cellular FLIP
49. The role of c-FLIP in modulation of CD95-induced apoptosis
50. Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses
51. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
52. Vascular platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells
53. Fas-mediated cytotoxicity by freshly isolated natural killer cells
54. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones